| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1995 Oxford University Press
RESEARCH-ARTICLE |
Mucopolysaccharidosis IVA: screening and identification of mutations of the N-acetylgalactosamine-6-sulfate sulfatase gene
Departments of Pediatrics, Gifu University School of Medicine 40 Tsukasa-machi, Gifu 500, Japan
*To whom correspondence should be addressed
Received October 7, 1994; Revised December 13, 1994; Accepted December 13, 1994
Mutations causing mucopolysaccharidosis IVA in 15 Japanese and one Caucasian patient were characterized. To screen these mutations, we used a combination of single strand conformation polymorphism analysis and heteroduplex analysis for PCR products of targeted cDNA or genomic DNA. Various small mutations were identified in 23 of 26 alleles, while the other six alleles had large rearrangements. Cycle sequencing of PCR products revealed 15 different mutations, including 12 missense, one nonsense, one frame shift (2 bp deletion) and one splice site mutation, in accord with the broad range of clinical phenotypes. Two alleles have different mutations in the same nucleotide position of exon 3 (R94C, CGC
TGC; R94G, CGC
GGC), diagnosed by sequencing and by allelic-specific oligohybridization (ASO). One allele had two amino acid changes, E450V in exon 12 and V488M in exon 13, thereby indicating a double point mutation. All 16 mutations reported were confirmed by restriction enzyme assay or by allelic-specific oligohybridization. Transfection of mutagenized cDNAs into patients fibroblasts showed that all mutations caused completely deficient or markedly decreased N-acetylgalactosamine-6-sulfate sulfatase (GALNS) activity, thereby indicating that these mutations were responsible for the enzyme deficiency.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Tomatsu, M. Gutierrez, T. Nishioka, M. Yamada, M. Yamada, Y. Tosaka, J. H. Grubb, A. M. Montano, M. B. Vieira, G. G. Trandafirescu, et al. Development of MPS IVA mouse (Galnstm(hC79S{middle dot}mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase Hum. Mol. Genet., November 15, 2005; 14(22): 3321 - 3335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sardiello, I. Annunziata, G. Roma, and A. Ballabio Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship Hum. Mol. Genet., November 1, 2005; 14(21): 3203 - 3217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Tomatsu, T Nishioka, A M Montano, M A Gutierrez, O S Pena, K O Orii, W S Sly, S Yamaguchi, T Orii, E Paschke, et al. Mucopolysaccharidosis IVA: identification of mutations and methylation study in GALNS gene J. Med. Genet., July 1, 2004; 41(7): e98 - e98. [Full Text] [PDF] |
||||
![]() |
S. Tomatsu, K. O. Orii, C. Vogler, J. Nakayama, B. Levy, J. H. Grubb, M. A. Gutierrez, S. Shim, S. Yamaguchi, T. Nishioka, et al. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease Hum. Mol. Genet., December 15, 2003; 12(24): 3349 - 3358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sukegawa, H. Nakamura, Z. Kato, S. Tomatsu, A. M. Montano, T. Fukao, G. Toietta, P. Tortora, T. Orii, and N. Kondo Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes Hum. Mol. Genet., May 22, 2000; 9(9): 1283 - 1290. [Abstract] [Full Text] [PDF] |
||||

